Drug profile · INN
tralokinumab
ADTRALZA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
tralokinumab (ADTRALZA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN tralokinumab
Brand ADTRALZA
Route INJECTION
Formulation INJECTABLE
ATC code D11
Frequently asked questions
What is tralokinumab?
tralokinumab (ADTRALZA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for tralokinumab?
ADTRALZA is a marketed brand name for tralokinumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tralokinumab?
tralokinumab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.